TLA TARGETED IMMUNOTHERAPIES AB has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets medical technology, measurement and biotechnology are TOPOSNOMOS LTD, TOKUSHIMA UNIVERSITY and DEUTSCHES ROTES KREUZ BLUTSPEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | United States | 8 | |
#3 | Australia | 2 | |
#4 | Hungary | 1 | |
#5 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Pharmaceuticals | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Syringes | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Chemical or physical processes | |
#6 | Medical preparations | |
#7 | Microorganisms | |
#8 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Winqvist Ola | 19 |
#2 | Cotton Graham | 17 |
#3 | Thoern Magnus | 1 |
#4 | Thorn Magnus | 1 |
#5 | Ola Winqvist | 1 |
#6 | Magnus Thorn | 1 |
#7 | Thörn Magnus | 1 |
#8 | Winqvist Ole | 1 |
Publication | Filing date | Title |
---|---|---|
US2014175018A1 | Diagnosing and treating inflammatory diseases | |
EP2718313A2 | Treating respiratory conditions | |
EP2718311A2 | Treating multiple sclerosis | |
EP2718312A2 | Treating conditions associated with sepsis | |
EP2718310A2 | Treating mental disorders | |
AU2007250552A1 | Method and means for treating inflammatory bowel disease |